SCHEMBL745718

SCHEMBL745718

CCCc1ccc(N2CCC3(CCN(S(=O)(=O)c4ccccc4S(C)(=O)=O)CC3)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 12/20 0.46
CYP3A4 P08684 11/20 0.46
CYP1A2 P05177 10/20 0.46
CYP2C19 P33261 9/20 0.46
ALDH1A1 P00352 7/20 0.46
CYP2D6 P10635 4/20 0.46
TSHR P16473 4/20 0.46
HIF1A Q16665 4/20 0.45
USP2 O75604 8/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
HSD17B10 Q99714 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 3/20 0.41
KCNH2 Q12809 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14238794 0.84 ALDH1A1 (0.37) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL746769 0.80 LIPE (0.50) CYP2C9CYP3A4CYP2C19TSHR
SCHEMBL746711 0.80 CYP2C9 (0.48) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL745542 0.76 CYP2C9 (0.52) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL746619 0.72 LIPE (0.47) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL744218 0.72 CYP3A4 (0.52) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL743380 0.71 LIPE (0.54) CYP2C9CYP3A4CYP2C19TSHR
SCHEMBL746622 0.70 CCR1 (0.44) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL747930 0.69 LIPE (0.44) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL746534 0.69 CYP3A4 (0.48) CYP2C9CYP3A4CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP disclosed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO disclosed